JO
KYNB

John Overdeck’s Kyntra Bio KYNB Stock Holding History

John Overdeck’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Sell
39,511
-10,000
-20% -$70.1K ﹤0.01% 4530
2026
Q1 		$336K Sell
49,511
-11,700
-19% -$91.6K ﹤0.01% 3996
2025
Q4 		$537K Buy
61,211
+20,993
+52% +$205K ﹤0.01% 3264
2025
Q3 		$493K Buy
40,218
+26,107
+185% +$245K ﹤0.01% 2993
2025
Q2 		$74.8K Sell
14,111
-9,267
-40% -$67.6K ﹤0.01% 3030
2025
Q1 		$181K Sell
23,378
-799
-3% -$9.58K ﹤0.01% 2870
2024
Q4 		$320K Buy
24,177
+3,956
+20% +$36.8K ﹤0.01% 2715
2024
Q3 		$202K Sell
20,221
-11,845
-37% -$179K ﹤0.01% 2797
2024
Q2 		$715K Sell
32,066
-345
-1% -$10.7K ﹤0.01% 2178
2024
Q1 		$1.9M Sell
32,411
-51,640
-61% -$2.22M ﹤0.01% 1520
2023
Q4 		$1.86M Buy
84,051
+9,523
+13% +$144K ﹤0.01% 1628
2023
Q3 		$1.61M Buy
74,528
+19,727
+36% +$775K ﹤0.01% 1580
2023
Q2 		$3.7M Buy
54,801
+17,485
+47% +$7.23M 0.01% 1070
2023
Q1 		$17.4M Buy
37,316
+14,749
+65% +$7.8M 0.05% 413
2022
Q4 		$9.04M Buy
22,567
+4,673
+26% +$1.79M 0.03% 601
2022
Q3 		$5.82M Sell
17,894
-5,345
-23% -$1.72M 0.02% 695
2022
Q2 		$6.13M Sell
23,239
-7,383
-24% -$1.89M 0.02% 685
2022
Q1 		$9.2M Sell
30,622
-10,546
-26% -$3.68M 0.03% 640
2021
Q4 		$14.5M Sell
41,168
-12,264
-23% -$3.82M 0.03% 608
2021
Q3 		$13.7M Buy
53,432
+43,360
+431% +$15.4M 0.03% 623
2021
Q2 		$6.71M Buy
10,072
+4,472
+80% +$2.58M 0.02% 1018
2021
Q1 		$4.86M Buy
5,600
+3,932
+236% +$4.19M 0.01% 1063
2020
Q4 		$1.55M Sell
1,668
-5,691
-77% -$5.98M ﹤0.01% 1671
2020
Q3 		$7.57M Sell
7,359
-2,950
-29% -$3.17M 0.03% 606
2020
Q2 		$10.4M Buy
10,309
+8,616
+509% +$8M 0.05% 377
2020
Q1 		$1.47M Sell
1,693
-2,985
-64% -$2.97M 0.01% 1148
2019
Q4 		$5.02M Sell
4,678
-4,177
-47% -$4.26M 0.02% 951
2019
Q3 		$8.19M Buy
8,855
+6,903
+354% +$7.58M 0.03% 624
2019
Q2 		$2.21M Sell
1,952
-721
-27% -$789K 0.01% 1387
2019
Q1 		$3.63M Buy
2,673
+1,726
+182% +$2.34M 0.01% 1131
2018
Q4 		$1.09M Buy
+947
New +$1.06M ﹤0.01% 1602
2018
Q3 		– Sell
-611
Closed -$956K – 3300
2018
Q2 		$956K Sell
611
-7,205
-92% -$9.39M ﹤0.01% 2181
2018
Q1 		$9.03M Buy
7,816
+6,703
+602% +$8.83M 0.03% 634
2017
Q4 		$1.32M Sell
1,113
-544
-33% -$682K ﹤0.01% 1760
2017
Q3 		$2.23M Buy
1,657
+1,325
+399% +$1.4M 0.01% 1252
2017
Q2 		$268K Sell
332
-1,818
-85% -$1.27M ﹤0.01% 2687
2017
Q1 		$1.32M Buy
+2,150
New +$1.31M ﹤0.01% 1734
2016
Q1 		– Sell
-1,128
Closed -$859K – 2905
2015
Q4 		$859K Buy
+1,128
New +$749K ﹤0.01% 1612

Other funds holding KYNB

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's KYNB Position: Q2 2026 in Review

John Overdeck reduced its Kyntra Bio (KYNB) stake by 20% in Q2 2026, selling an estimated $70.1K and leaving 39,511 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #4530.

John Overdeck first reported a position in KYNB in Q4 2015 and has held it in 38 quarters since. The position peaked at $17.4M in Q1 2023. 27 funds tracked by Wall St. Rank hold KYNB as of Q2 2026.

  • John Overdeck held 39,511 shares of Kyntra Bio worth $298K as of Q2 2026.
  • John Overdeck sold 10,000 Kyntra Bio shares in Q2 2026, an estimated $70.1K.
  • Kyntra Bio made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4530 holding.
  • John Overdeck first reported a position in Kyntra Bio in Q4 2015 and has held it in 38 quarters since.
  • John Overdeck's Kyntra Bio position peaked at $17.4M in Q1 2023.
  • 27 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.